Skip to main content

Table 1 Characteristics of included studies

From: Effect of curcumin supplement or placebo in delayed onset muscle soreness: a systematic review and meta-analysis

Author

Year

Country

N

nc

np

RCT

N (men)

BMI

Preparation

Exercise

Age (mean)

Dose

Outcome

Drobnic F

2014

Spain

19

9

10

Parallel

19

24.6

Meriva

Downhill running

35.4

1 g bid

VAS CK

Nicol LM

2015

New Zealand

17

17

17

Crossover

17

-

Capsules

Leg press

33.8

2.5 gm bid

VAS CK TNF IL

Tanabe Y

2015

japan

14

14

14

Crossover

14

22

Theracurmin

Elbow flexor

23.5

150 mg bid

VAS CK TNF IL ROM

McFarlin BK

2016

USA

28

14

14

Parallel

10

22.5

Longvida

Leg press

19.5

200, 400, 1000 mg

VAS CK TNF IL

Naknhostin-Roohi B

2016

Iran

10

10

10

Crossover

10

25.6

Theracurmin

squat exercises

25

150 mg

VAS CK

Basham SA

2019

USA

20

20

20

Crossover

20

26.7

CurcuFresh

Leg press

21.7

1.5 g

VAS CK TNF

Amalraj A

2020

India

30

15

15

Parallel

12

23.3

AB

Downhill running

36

500 mg

VAS CK

Jäger R

2019

USA

63

42

21

Parallel

31

25.6

CurcuWIN

Downhill running

21

50, 200 mg

VAS

Tanabe Y

2019

japan

24

16

8

Parallel

24

22.1

Theracurmin

Elbow flexor

28.3

180 mg 7 day

VAS CK ROM

Tanabe Y scan

2019

japan

20

10

10

Parallel

20

23.5

Theracurmin

Elbow flexors

28.75

180 mg

VAS CK TNF IL ROM

Cardaci TD

2020

USA

23

11

12

Parallel

11

24.6

UPS

Treadmill

21.13

2 g

VAS

Mallard AR

2020

New Zealand

27

13

14

Parallel

27

25.6

LipiSperse

LL resistance

26

427 mg

VAS CK TNF IL

Hillman AR

2021

USA

22

11

11

Parallel

17

25.4

Capsules

Plyometric

21.5

475 mg

VAS CK

  1. UPS ubiquitin proteasome system, LL lower limb, AB aurea biolabs